Biotech Market Forecast: Top Trends for Biotech in 2026

2025-12-23 16:15:00 ET

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is setting the stage for a continued recovery, driven in part by the integration of artificial intelligence (AI).

The current optimism is shared by experts like Dr. David Song, a portfolio manager at Tema Healthcare funds, who conveyed his view to the Investing News Network (INN).

However, this sectoral resurgence must navigate a tug-of-war between supportive stimulus and structural risks, which have the potential to challenge the pace of recovery.

For further details see: